Evidence map›Paper›PMID 42809925›Full record

ArticleRedox biology2026

The ribonuclease ZC3H12A stabilizes BRCA1 mRNA in DNA damage response.

Mingjun Lu, Jiabao Hou, Zhendong Qin, Jingwei Guo, Jinghong Wu, Chenyang Wang, Jiaqi Zhao, Xiaoyue Zhu, Teng Ma

Abstract read
In one paragraph

Article in Redox biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mingjun LuCancer Research Center, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, 101149, China.
Jiabao HouCancer Research Center, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, 101149, China.
Zhendong QinCancer Research Center, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, 101149, China.
Jingwei GuoCancer Research Center, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, 101149, China.
Jinghong WuCancer Research Center, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, 101149, China.
Chenyang WangCancer Research Center, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, 101149, China.
Jiaqi ZhaoCancer Research Center, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, 101149, China.
Xiaoyue ZhuCancer Research Center, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, 101149, China.
Teng MaCancer Research Center, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, 101149, China. Electronic address: mateng82913@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ZC3H12A is an endoribonuclease that destabilizes target transcripts by recognizing stem-loop structures containing a pyrimidine-purine-pyrimidine loop. Here, we identify ZC3H12A as a constitutive stabilizer of BRCA1 mRNA that supports DNA repair capacity. Under basal conditions, depletion of ZC3H12A shortens the half-life of BRCA1 mRNA, reduces its ribosomal loading and lowers BRCA1 protein levels, whereas overexpression has the opposite effect. ZC3H12A binds to the BRCA1 transcript via its PilT N-terminal (PIN) and CCCH-type zinc finger (ZF) domains; enhanced crosslinking and immunoprecipitation (eCLIP) narrows the bound sequence to defined intervals that lie outside the canonical stem-loop element through which ZC3H12A recognizes inflammatory transcripts. Moreover, ionizing radiation induces TBK1-dependent phosphorylation of ZC3H12A at Ser386, accompanied by the export of ZC3H12A from the nucleus and its redistribution to cytoplasmic ribosomes. Phosphorylated ZC3H12A occupies a broader region of BRCA1 transcript without promoting its degradation, thereby further prolonging its half-life and increasing its ribosomal loading. As a result, under genotoxic stress, the supply of BRCA1 increases, thereby supporting RAD51 recruitment and homologous recombination repair. These findings identify ZC3H12A as a post-transcriptional regulator of BRCA1 mRNA and show how Ser386 phosphorylation amplifies a protective function that is already present before damage.

Indexed as

BRCA1DNA damage responseHomologous recombinationmRNA stabilityTBK1ZC3H12A

Identifiers

PMID42809925
PMCPMC13653440

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.